Dana, Nasim, et al. “PPAR γ Agonist, Pioglitazone, Suppresses Melanoma Cancer in Mice by Inhibiting TLR4 Signaling”. Journal of Pharmacy & Pharmaceutical Sciences, vol. 22, no. 1, Sept. 2019, pp. 418-23, doi:10.18433/jpps30626.